The majority of ICCR Datasets scheduled to be developed will be in response to updates of the World Health Organization (WHO) Classification of Tumours or applicable staging system. However, additional datasets are scheduled where there are specific needs to be addressed and resources available.
The WHO Classification of Tumours ‘Blue book’ revisions for Endocrine neoplasms is now published and the ICCR has therefore developed a series of four datasets in this area:
Public consultation is planned for July 2019.
- Adrenal cortical gland
- Phaeochromoctyoma and paraganglioma
The ICCR has commenced development of a series of five datasets for the digestive tract:
Public consultation is expected to be in late 2019.
- Exocrine pancreas
The ICCR has commenced development of a series of three datasets for breast:
Public consultation is expected early 2020.
- Invasive breast cancer
- Ductal carcinoma in situ (DCIS)
- Lymph node dissection/sentinel node biopsy
BONE AND SOFT TISSUE
In synchrony with the updates to the WHO classification of Tumours for Bone and Soft Tissue, the ICCR is planning the development of 3 datasets:
- Soft Tissue Sarcoma
- Gastrointestinal Stromal Tumours (GIST)
With the release of the 8th edition of TNM staging, impacted ICCR datasets have been updated - Lung, Endometrial, Thymic and Mesothelioma and posted to the website. Invasive cutaneous melanoma still requires an update to TNM8 and this will be undertaken in 2019 as part of the development of the Skin suite of datasets.